Literature DB >> 21553609

Comparison of definitions of metabolic syndrome in relation to risk for coronary artery disease and stroke.

Nuno Cortez-Dias1, Susana Martins, Adriana Belo, Manuela Fiuza.   

Abstract

OBJECTIVES: To compare definitions of metabolic syndrome (MS) in relation to their association with coronary artery disease (CAD) and stroke.
METHODS: We performed a cross-sectional study in a primary care setting, involving 719 general practitioners and based on stratified distribution proportional to the population density. The first two adult patients scheduled for an appointment on a given day were invited to participate, irrespective of the reason for the consultation. A questionnaire was applied to record sociodemographic, clinical and laboratory data. A diagnosis of MS was defined according to NCEP-ATP III 2001, NCEP-ATP III 2004, IDF and AHA/NHLBI criteria. Multivariate logistic regression analysis was used to assess the risk of CAD and stroke according to gender, age, body mass index, waist circumference, HDL cholesterol, triglycerides, hypertension, diabetes and MS according to each definition.
RESULTS: The study included 16,856 individuals (age 58.1 +/- 15.1 years). The prevalence of MS adjusted for gender, age and region size according to the 2001 and 2004 NCEP-ATP III, IDF and AHA/NHLBI definitions was 28.4%, 32.8%, 65.5% and 69.4%, respectively. The degree of agreement according to k statistics was modest and only 60.3% simultaneously fulfilled the criteria of all definitions. Hypertension was the treatable risk factor most strongly associated with CAD and stroke. Only the IDF and AHA/NHLBI definitions of MS were independently associated with CAD (OR: 1.74 and 2.26, respectively). Regarding stroke, only the AHA/NHLBI criteria showed a statistically significant association (OR: 1.85).
CONCLUSIONS: MS as defined according to the AHA/NHLBI criteria appears to be the best predictor of CAD and stroke in the Portuguese population, and remains an independent risk factor for CAD and stroke after adjustment for its individual components.

Entities:  

Mesh:

Year:  2011        PMID: 21553609

Source DB:  PubMed          Journal:  Rev Port Cardiol        ISSN: 0870-2551            Impact factor:   1.374


  7 in total

1.  Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association.

Authors:  James F Meschia; Cheryl Bushnell; Bernadette Boden-Albala; Lynne T Braun; Dawn M Bravata; Seemant Chaturvedi; Mark A Creager; Robert H Eckel; Mitchell S V Elkind; Myriam Fornage; Larry B Goldstein; Steven M Greenberg; Susanna E Horvath; Costantino Iadecola; Edward C Jauch; Wesley S Moore; John A Wilson
Journal:  Stroke       Date:  2014-10-28       Impact factor: 7.914

2.  Cerebral blood flow and cognitive function in patients with metabolic syndrome: effect of antihypertensive therapy.

Authors:  Irina Efimova; Natalya Efimova; Yuri Lishmanov
Journal:  J Clin Hypertens (Greenwich)       Date:  2014-11-10       Impact factor: 3.738

3.  Impact of a physician-supervised exercise-nutrition program with testosterone substitution in partial androgen-deficient middle-aged obese men.

Authors:  Ernst R Schwarz; Robert D Willix
Journal:  J Geriatr Cardiol       Date:  2011-12       Impact factor: 3.327

4.  Prevalence and determinants of metabolic syndrome among adults in a rural area of Northwest China.

Authors:  Yaling Zhao; Hong Yan; Ruihai Yang; Qiang Li; Shaonong Dang; Yuying Wang
Journal:  PLoS One       Date:  2014-03-10       Impact factor: 3.240

5.  Diastolic dysfunction in the diabetic continuum: association with insulin resistance, metabolic syndrome and type 2 diabetes.

Authors:  Ricardo Fontes-Carvalho; Ricardo Ladeiras-Lopes; Paulo Bettencourt; Adelino Leite-Moreira; Ana Azevedo
Journal:  Cardiovasc Diabetol       Date:  2015-01-13       Impact factor: 9.951

6.  The prevalence of the metabolic syndrome in Portugal: the PORMETS study.

Authors:  Luís Raposo; Milton Severo; Henrique Barros; Ana Cristina Santos
Journal:  BMC Public Health       Date:  2017-06-08       Impact factor: 3.295

7.  Metabolic syndrome in ischemic stroke: A case control study.

Authors:  Fereshteh Ashtari; Mehri Salari; Ashraf Aminoroaya; Behnaz Khademi Deljoo; Mina Moeini
Journal:  J Res Med Sci       Date:  2012-02       Impact factor: 1.852

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.